Skip to main content
Clinical Trials/ITMCTR1900002792
ITMCTR1900002792RecruitingPhase 1

Evaluation of the clinical efficacy of Shenshuaining capsule in the treatment of end-stage renal disease with peritoneal dialysis

The First Affiliated Hospital of Chengdu Medical College0 sitesStarted: TBDLast updated:

Trial Snapshot

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
18 to — (—)
Sex
All

Inclusion Criteria

  • 1. Aged over 18 years male and female;
  • 2. Clear consciousness;
  • 3. Regular peritoneal dialysis was performed and the urine volume was > 100ml at 24 hours;
  • 4. Patients with stable condition who insist on regular review of relevant indicators every 3 months;
  • 5. Volunteer to participate in this study and sign the informed consent;
  • 6. Chinese medicine dialectic is the spleen of the spleen or the spleen and blood bruising.

Exclusion Criteria

  • 1. Allergic constitution or allergic to a variety of drugs;
  • 2. There are serious digestive tract diseases that affect drug absorption,such as active ulcer,Chronic diarrhea,etc.;
  • 3. A woman who is pregnant or breast-feeding;
  • 4. Inability to cooperate, as with a psychopath;
  • 5. Alcohol or drug abusers;
  • 6. Patients who had been given Niaoduqing Particles before enrollment;
  • 7. Drugs containing rhubarb were used before enrollment or during the trial.

Investigators

Similar Trials